Waters
WAT
440.45
-16.03
-3.51%
Waters
US · WAT
#515 by market cap
Listed 1970
440.45
-16.03
-3.51%
Periodic snapshot; not a real-time feed.
· 2026-11-20 20:02
✦ Quant Ownership Signal how this is computed
Distributing
- The number of reporting institutions decreased by 3 in the most recent period (2026/Q4).
- Total institutional ownership (as a % of shares) was little changed.
Ownership vs. money flow
AlignedInstitutions trimmed shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two line up.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Institutional ownership
- Held by institutions
- 100.15% -0.04pp
- Institutions
- 1,481 -3
- As of
- 2026/Q4 vs. prior period
Holder types
Mutual Fund87.75%
Hedge Fund5.76%
Public Company2.62%
Government Pension Fund1.48%
Private Company1.09%
VC/PE Fund0.44%
Insurance Company0.26%
Sovereign Wealth Fund0.25%
Family Office/Trust0.18%
Other0.17%
Top holders as of 2026-09-30
BlackRock
8.80% · 8.64M sh
Vanguard Capital Management, LLC
7.11% · 6.98M sh
T. Rowe Price Group, Inc.
5.14% · 5.05M sh
Vanguard Portfolio Management, LLC
4.89% · 4.81M sh
State Street Global Advisors
4.50% · 4.42M sh
MFS Investment Management
4.12% · 4.05M sh
FMR
3.53% · 3.47M sh
Geode Capital Management, LLC
2.70% · 2.66M sh
AllianceBernstein
2.57% · 2.52M sh
Invesco Ltd.
2.45% · 2.41M sh
Fundsmith, LLP
2.31% · 2.27M sh
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
50 filings tracked · 36 buys · 9 sells
| Name | Role | Stake |
|---|---|---|
| Udit Batra | Chief Executive Officer | 0.03% |
| Christopher Kuebler | Independent Director | 0.02% |
| Amol Chaubal | Senior Vice President | 0.01% |
| Flemming Ornskov | Independent Chairperson | 0.01% |
| Jianqing Bennett | Senior Vice President of Waters Advanced Diagnostics Division | 0.01% |
| Mark Vergnano | Independent Director | 0.00% |
| Wei Jiang | Independent Director | 0.00% |
| Richard Fearon | Independent Director | 0.00% |
| Linda Baddour | Independent Director | 0.00% |
| Pearl Huang | Independent Director | 0.00% |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-10-28 | Steve Conly | Senior Vice President of Waters Biosciences Division | Initial Statement of Beneficial | 0 | -- |
| 2026-09-29 | Wei Jiang | Independent Director | Other Acquisition | +57 | -- |
| 2026-09-29 | Heather Knight | Independent Director | Other Acquisition | +57 | -- |
| 2026-08-05 | Christopher Kuebler | Independent Director | Derivative Exercise and Sale | -3,626 | $136.43–397.94 |
| 2026-06-29 | Wei Jiang | Independent Director | Other Acquisition | +67 | -- |
| 2026-06-29 | Heather Knight | Independent Director | Other Acquisition | +63 | -- |
| 2026-06-23 | Robert Carpio | Former Senior Vice President of Waters Analytical Sciences | Sale to Issuer | -189 | $369.18 |
| 2026-05-11 | Amol Chaubal | Senior Vice President | Sale to Issuer | -239 | $352.21 |
| 2026-04-05 | Jianqing Bennett | Senior Vice President of Waters Advanced Diagnostics Division | Sale to Issuer | -302 | $304.09 |
| 2026-03-30 | Wei Jiang | Independent Director | Other Acquisition | +64 | -- |
| 2026-03-30 | Heather Knight | Independent Director | Other Acquisition | +68 | -- |
| 2026-03-15 | Wei Jiang | Independent Director | Open Market Acquisition | +500 | $289.46 |
| 2026-03-05 | Richard Fearon | Independent Director | Open Market Acquisition | +1,000 | $306.34 |
| 2026-03-01 | Udit Batra | Chief Executive Officer | Sale to Issuer | -3,417 | $307.23 |
| 2026-03-01 | Jianqing Bennett | Senior Vice President of Waters Advanced Diagnostics Division | Sale to Issuer | -410 | $307.23 |
| 2026-03-01 | Amol Chaubal | Senior Vice President | Sale to Issuer | -709 | $307.23 |
| 2026-02-24 | Linda Baddour | Independent Director | Other Acquisition | +23 | -- |
| 2026-02-24 | Linda Baddour | Independent Director | Other Derivative Acquisition | +57 | $319.44 |
| 2026-02-24 | Christopher Kuebler | Independent Director | Other Acquisition | +23 | -- |
| 2026-02-24 | Christopher Kuebler | Independent Director | Other Derivative Acquisition | +57 | $319.44 |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-11-20 20:02:20 · For reference only, not investment advice and not tailored to your situation.
Waters discussion 0 comments